Aarey Drugs shines on commencing second phase of production at its Tarapur facility

26 Aug 2016 Evaluate

Aarey Drugs & Pharmaceuticals is currently trading at Rs. 40.90, up by 1.15 points or 2.89% from its previous closing of Rs. 39.75 on the BSE.

The scrip opened at Rs. 40.00 and has touched a high and low of Rs. 41.50 and Rs. 40.00 respectively. So far 34250 shares were traded on the counter.

The BSE group 'XD' stock of face value Rs. 10 has touched a 52 week high of Rs. 57.00 on 10-Jun-2016 and a 52 week low of Rs. 12.26 on 09-Sep-2015.

Last one week high and low of the scrip stood at Rs. 43.00 and Rs. 39.10 respectively. The current market cap of the company is Rs. 72.25 crore.

The promoters holding in the company stood at 57.44%, while institutions and non-institutions held 0.24% and 42.32% respectively.

Aarey Drugs & Pharmaceuticals has commenced with it second phase of production of drug Intermediate i.e. Di-Methyl Urea in API segment at its factory located at E-34, MIDC, Tarapur, Boisar in Thane from August 16, 2016, after successful trial run, and product has been accepted in local market.

The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

Aarey Drugs & Pharma Share Price

54.58 -2.87 (-5.00%)
13-Jan-2025 14:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1746.00
Dr. Reddys Lab 1334.10
Cipla 1440.60
Lupin 2148.00
Zydus Lifesciences 969.45
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.